Evaluation of Imidazole‐Based Compounds as Heme Oxygenase‐1 Inhibitors
- 9 October 2012
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 80 (6) , 876-886
Abstract
Imidazole‐based compounds previously synthesized in our laboratory were selected and reconsidered as inhibitors of heme oxygenase‐1 obtained from the microsomal fractions of rat spleens. Most of tested compounds were good inhibitors with IC50 values in the low micromolar range. Compounds were also assayed on membrane‐free full‐length recombinant human heme oxygenase‐1; all tested compounds were unable to interact with human heme oxygenase‐1 at 100 μm concentrations with the exception of compounds 11 and 13 that inhibited the enzyme of 54% and 20%, respectively. The binding of the most active compound 11 with heme or heme‐conjugated human heme oxygenase‐1 was also examined by spectral analyses. When heme was not conjugated to human heme oxygenase‐1, compound 11 caused changes in the heme spectrum only at concentration 50‐fold (100 μm) higher than that required to inhibit rat heme oxygenase‐1; when heme was conjugated to human heme oxygenase‐1, compound 11 was able to form a heme‐compound 11 complex also at low micromolar concentrations. To obtain information on the binding mode of the tested compounds with enzyme, docking studies and pharmacophore analysis were performed. Template docking results were in agreement with experimental inhibition data and with a structure‐based pharmacophoric model. These data may be exploitable to design new OH‐1 inhibitors.Keywords
This publication has 56 references indexed in Scilit:
- Recombinant truncated and microsomal heme oxygenase-1 and -2: differential sensitivity to inhibitorsCanadian Journal of Physiology and Pharmacology, 2010
- Structural characterization of human heme oxygenase-1 in complex with azole-based inhibitorsJournal of Inorganic Biochemistry, 2010
- Measurement of Membrane-Bound Human Heme Oxygenase-1 Activity Using a Chemically Defined Assay SystemDrug Metabolism and Disposition, 2009
- C-Terminal Membrane Spanning Region of Human Heme Oxygenase-1 Mediates a Time-Dependent Complex Formation with Cytochrome P450 ReductaseBiochemistry, 2008
- Expression and Characterization of Full-Length Human Heme Oxygenase-1: The Presence of Intact Membrane-Binding Region Leads to Increased Binding Affinity for NADPH Cytochrome P450 ReductaseBiochemistry, 2007
- Overexpression of Heme Oxygenase-1 in Murine MelanomaThe American Journal of Pathology, 2006
- Inhibition of heme oxygenase‐1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL miceInternational Journal of Cancer, 2006
- Inhibition of the Enzymatic Activity of Heme Oxygenases by Azole-Based Antifungal DrugsThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in miceNature Medicine, 2002
- Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data, and empirical rulesJournal of Computational Chemistry, 1996